C12N2795/18123 - CPC Classification Index

#1

20260130979

2026-05-14

MALARIA IMMUNOGEN AND METHODS OF USING SAME

#2

20250332278

2025-10-30

MULTIVALENT DISPLAY OF APOAI PEPTIDE ON NANOPARTICLES AGAINST ATHEROSCLEROSIS

#3

20250302940

2025-10-02

PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR

#4

20250241999

2025-07-31

DELIVERY OF THERAPEUTIC RECOMBINANT URICASE USING NANOPARTICLES

#5

20250084479

2025-03-13

METHODS AND COMPOSITIONS FOR DETERMINING THE ANTIGEN SPECIFICITY OF T CELLS

#6

20250042962

2025-02-06

COMPOSITIONS TARGETING APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN WITH CASPASE ACTIVATION AND RECRUITMENT DOMAIN (ASC) AND METHODS OF USE

#7

20250019695

2025-01-16

PACKAGING OLIGONUCLEOTIDES INTO VIRUS-LIKE PARTICLES

#8

20240316174

2024-09-26

BACTERIOPHAGE VIRUS-LIKE PARTICLE VACCINES AGAINST FLAVIVIRUS NON-STRUCTURAL PROTEIN 1

#9

20240299512

2024-09-12

IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE

#10

20240279295

2024-08-22

Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use

#11

20240197845

2024-06-20

IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE

#12

20240156937

2024-05-16

BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS

#13

20220304315

2022-09-29

METHODS AND COMPOSITIONS FOR MICROBIAL DELIVERY OF DOUBLE STRANDED RNA

#14

20210261958

2021-08-26

Packaging oligonucleotides into virus-like particles

#15

20210253641

2021-08-19

EGFRvIII immunogen and methods for using same

#16

20210236608

2021-08-05

Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same

#17

20200397891

2020-12-24

Compositions and methods for reducing serum triglycerides

#18

20190328854

2019-10-31

C5 IMMUNIZATION FOR AUTOLOGOUS ANTI-C5 ANTIBODY PRODUCTION

#19

20190134170

2019-05-09

Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same

#20

20190038735

2019-02-07

VLP-based vaccines for targeting secreted virulence factors

#21

20180291066

2018-10-11

IN VIVO PRODUCTION OF LONG DOUBLE STRANDED RNA UTILIZING VLPS

#22

20180171358

2018-06-21

Oligonucleotides packaged into virus-like particles of RNA bacteriophages

#23

20180050097

2018-02-22

IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE

#24

20180030445

2018-02-01

Compositions and methods using capsids resistant to hydrolases

#25

20170189503

2017-07-06

PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same

#26

20160228525

2016-08-11

Malaria vaccine

#27

20160208221

2016-07-21

COMPOSITIONS AND METHODS USING CAPSIDS RESISTANT TO HYDROLASES

#28

20160194632

2016-07-07

Targeting non-coding RNA for RNA interference

#29

20160194613

2016-07-07

Compositions and methods for inhibiting gene expressions

#30

20150315246

2015-11-05

Scalable process for protein purification

#31

20150004688

2015-01-01

Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages

#32

20140302593

2014-10-09

Process for purifying VLPs

#33

20140186405

2014-07-03

Processes for packaging aggregated oligonucleotides into virus-like particles of RNA bacteriophages

#34

20120308592

2012-12-06

Immunogenic HPV L2-containing VLPs and related compositions, constructs, and therapeutic methods

#35

20120214976

2012-08-23

Scalable Process for Protein Purification

#36

20120015899

2012-01-19

MODIFIED PLANT VIRUS PARTICLES AND USES THEREFOR

#37

20110318300

2011-12-29

User of Interleukin-1 Conjugates in the Treatment of Diabetes

#38

20110306113

2011-12-15

Scalable Process for Protein Purification

#39

20110262472

2011-10-27

VACCINE COMPOSITIONS FOR THE TREATMENT OF DENGUE FEVER AND USES THEREOF

#40

20110212122

2011-09-01

Nerve Growth Factor Conjugates and Uses Thereof

#41

20110104203

2011-05-05

VIRUS-LIKE PLATFORM FOR RAPID VACCINE DISCOVERY

#42

20110091411

2011-04-21

Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases

#43

20110027220

2011-02-03

Interleukin-1 Conjugates and Uses Thereof

#44

20100303846

2010-12-02

Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity

#45

20100273237

2010-10-28

Process for producing aggregated oligonucleotides

#46

20100168402

2010-07-01

Direct Attachment of Polypeptides to Virus Like Particles

#47

20100129395

2010-05-27

Hapten-carrier conjugates and uses thereof

#48

20100111995

2010-05-06

Antigen conjugates and uses thereof

#49

20100098722

2010-04-22

Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use

#50

20100092508

2010-04-15

Molecular Antigen Arrays

#51

20090317861

2009-12-24

CELL-FREE SYNTHESIS OF VIRUS LIKE PARTICLES

#52

20090054246

2009-02-26

Virus-like platform for rapid vaccine discovery

#53

20090048433

2009-02-19

Scalable process for protein purification

#54

20080292652

2008-11-27

Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide

#55

20080095738

2008-04-24

VLP-antigen conjugates and their uses as vaccines

#56

20070248617

2007-10-25

Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides

#57

20070184068

2007-08-09

Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity

#58

20070128219

2007-06-07

Molecular antigen arrays

#59

20060257889

2006-11-16

Ribonuclease resistant RNA preparation and utilization

#60

20060251677

2006-11-09

Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use

#61

20060210588

2006-09-21

Hiv-peptide-carrier-conjugates

#62

20050281845

2005-12-22

Hapten-carrier conjugates and uses thereof